Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0

G. E. Calabro; S. Boccalini; A. Bechini; D. Panatto; A. Domnich; P. L. Lai; D. Amicizia; C. Rizzo; A. Pugliese; Maria Luisa Di Pietro; B. Zanella; F. Parente; C. S. Trombetta; G. Saraceno; S. Sottile; F. M. Abreha; I. Giacchetta; S. Properzi; G. Santolini; F. D'Ambrosio; A. Maida; A. Scardigno; Gatta E. LA; L. Petrella; P. Bonanni; Waure C. DE

doi:10.15167/2421-4248/jpmh2022.63.4s1

Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0

G. E. Calabro
, S. Boccalini
, A. Bechini
, D. Panatto
, A. Domnich
, P. L. Lai
, D. Amicizia
, C. Rizzo
, A. Pugliese
, Maria Luisa Di Pietro
, B. Zanella
, F. Parente
, C. S. Trombetta
, G. Saraceno
, S. Sottile
, F. M. Abreha
, I. Giacchetta
, S. Properzi
, G. Santolini
, F. D'Ambrosio

A. Maida, A. Scardigno, Gatta E. LA, L. Petrella, P. Bonanni, Waure C. DE

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

No avalilable

Lingua originale	Italian
pagine (da-a)	E1-E140
Numero di pagine	140
Rivista	Journal of Preventive Medicine and Hygiene
Volume	63
Numero di pubblicazione	4
DOI	https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1
Stato di pubblicazione	Pubblicato - 2022

All Science Journal Classification (ASJC) codes

Medicina Generale

Keywords

health technology assessment
cell-culture-derived quadrivalent influenza vaccine

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.15167/2421-4248/jpmh2022.63.4s1

Altri file e collegamenti

Cita questo

Calabro, G. E., Boccalini, S., Bechini, A., Panatto, D., Domnich, A., Lai, P. L., Amicizia, D., Rizzo, C., Pugliese, A., Di Pietro, M. L., Zanella, B., Parente, F., Trombetta, C. S., Saraceno, G., Sottile, S., Abreha, F. M., Giacchetta, I., Properzi, S., Santolini, G., ... DE, W. C. (2022). Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0. Journal of Preventive Medicine and Hygiene, 63(4), E1-E140. https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1

@article{e7072212e2224c508a4897d1361ce7f0,

title = "Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra{\textregistered} 2.0",

abstract = "No avalilable",

keywords = "health technology assessment, cell-culture-derived quadrivalent influenza vaccine, health technology assessment, cell-culture-derived quadrivalent influenza vaccine",

author = "Calabro, \{G. E.\} and S. Boccalini and A. Bechini and D. Panatto and A. Domnich and Lai, \{P. L.\} and D. Amicizia and C. Rizzo and A. Pugliese and \{Di Pietro\}, \{Maria Luisa\} and B. Zanella and F. Parente and Trombetta, \{C. S.\} and G. Saraceno and S. Sottile and Abreha, \{F. M.\} and I. Giacchetta and S. Properzi and G. Santolini and F. D'Ambrosio and A. Maida and A. Scardigno and LA, \{Gatta E.\} and L. Petrella and P. Bonanni and DE, \{Waure C.\}",

year = "2022",

doi = "10.15167/2421-4248/jpmh2022.63.4s1",

language = "Italian",

volume = "63",

pages = "E1--E140",

journal = "Journal of Preventive Medicine and Hygiene",

issn = "1121-2233",

publisher = "Pacini Editore Srl",

number = "4",

}

Calabro, GE, Boccalini, S, Bechini, A, Panatto, D, Domnich, A, Lai, PL, Amicizia, D, Rizzo, C, Pugliese, A, Di Pietro, ML, Zanella, B, Parente, F, Trombetta, CS, Saraceno, G, Sottile, S, Abreha, FM, Giacchetta, I, Properzi, S, Santolini, G, D'Ambrosio, F, Maida, A, Scardigno, A, LA, GE, Petrella, L, Bonanni, P & DE, WC 2022, 'Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0', Journal of Preventive Medicine and Hygiene, vol. 63, n. 4, pagg. E1-E140. https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1

Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0. / Calabro, G. E.; Boccalini, S.; Bechini, A. et al.
In: Journal of Preventive Medicine and Hygiene, Vol. 63, N. 4, 2022, pag. E1-E140.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0

AU - Calabro, G. E.

AU - Boccalini, S.

AU - Bechini, A.

AU - Panatto, D.

AU - Domnich, A.

AU - Lai, P. L.

AU - Amicizia, D.

AU - Rizzo, C.

AU - Pugliese, A.

AU - Di Pietro, Maria Luisa

AU - Zanella, B.

AU - Parente, F.

AU - Trombetta, C. S.

AU - Saraceno, G.

AU - Sottile, S.

AU - Abreha, F. M.

AU - Giacchetta, I.

AU - Properzi, S.

AU - Santolini, G.

AU - D'Ambrosio, F.

AU - Maida, A.

AU - Scardigno, A.

AU - LA, Gatta E.

AU - Petrella, L.

AU - Bonanni, P.

AU - DE, Waure C.

PY - 2022

Y1 - 2022

N2 - No avalilable

AB - No avalilable

KW - health technology assessment

KW - cell-culture-derived quadrivalent influenza vaccine

KW - health technology assessment

KW - cell-culture-derived quadrivalent influenza vaccine

UR - https://publicatt.unicatt.it/handle/10807/327739

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85152170755&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85152170755&origin=inward

U2 - 10.15167/2421-4248/jpmh2022.63.4s1

DO - 10.15167/2421-4248/jpmh2022.63.4s1

M3 - Articolo

SN - 1121-2233

VL - 63

SP - E1-E140

JO - Journal of Preventive Medicine and Hygiene

JF - Journal of Preventive Medicine and Hygiene

IS - 4

ER -